FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4205741365> ?p ?o ?g. }

• W4205741365 abstract "The overall outcomes for patients with advanced liver cancer are far from satisfactory, and the development of more effective therapeutic strategies for liver cancer is required. Sulforhodamine blue and colony formation assays were performed to detect the proliferation of liver certain cancer cells, including HepG2 and Hep3B. Western blotting was also preformed to detect the expression of indicated proteins, including cleaved‑caspase‑3, cleaved‑poly (ADP‑ribose) polymerase, dual‑specificity tyrosine phosphorylation kinase 1A (DYRK1A), PARP‑1/2, GAPDH, myeloid cell leukemia‑1, phosphorylated‑AKT (Ser473), caspase‑3, α‑tubulin and AKT. PI staining was used to detect cell death. In the present study, DYRK1A knockdown significantly enhanced the anti‑liver cancer effect of regorafenib <em>in vitro</em>. Furthermore, DYRK1A inhibitor harmine together with regorafenib provided synergistic anti‑liver cancer activity by suppressing cell proliferation. In addition, harmine significantly enhanced regorafenib‑induced cell death in liver cancer cells. It has been reported that AKT signaling is activated in regorafenib‑resistant cancer cells and plays a crucial role in the regulation of cellular sensitivity to regorafenib. In the present study, AKT was activated in regorafenib‑treated cells, and harmine could suppress the activation of AKT and reinforce the anti‑cancer effects of regorafenib via regulating AKT in liver cancer cells. These data indicated that harmine enhanced the anti‑cancer effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells via regulating the activation of AKT, and harmine plus regorafenib may be a potential therapeutic regimen for treating patients with liver cancer." @default.
• W4205741365 created "2022-01-26" @default.
• W4205741365 creator A5023541354 @default.
• W4205741365 creator A5027312456 @default.
• W4205741365 creator A5031337173 @default.
• W4205741365 creator A5036476484 @default.
• W4205741365 creator A5038839605 @default.
• W4205741365 creator A5047835985 @default.
• W4205741365 creator A5068252474 @default.
• W4205741365 creator A5089119541 @default.
• W4205741365 date "2022-01-07" @default.
• W4205741365 modified "2023-09-26" @default.
• W4205741365 title "Harmine reinforces the effects of regorafenib on suppressing cell proliferation and inducing apoptosis in liver cancer cells" @default.
• W4205741365 cites W1605728736 @default.
• W4205741365 cites W1746221876 @default.
• W4205741365 cites W1816421912 @default.
• W4205741365 cites W1963875364 @default.
• W4205741365 cites W1968209756 @default.
• W4205741365 cites W1982861164 @default.
• W4205741365 cites W2015401427 @default.
• W4205741365 cites W2019961689 @default.
• W4205741365 cites W2027542963 @default.
• W4205741365 cites W2068720063 @default.
• W4205741365 cites W2069002336 @default.
• W4205741365 cites W2075734310 @default.
• W4205741365 cites W2084136291 @default.
• W4205741365 cites W2105637242 @default.
• W4205741365 cites W2130625735 @default.
• W4205741365 cites W2149988506 @default.
• W4205741365 cites W2154641741 @default.
• W4205741365 cites W2170311998 @default.
• W4205741365 cites W2575811573 @default.
• W4205741365 cites W2598230851 @default.
• W4205741365 cites W2765565477 @default.
• W4205741365 cites W2792376809 @default.
• W4205741365 cites W2793421498 @default.
• W4205741365 cites W2895964723 @default.
• W4205741365 cites W2906272152 @default.
• W4205741365 cites W2909506514 @default.
• W4205741365 cites W2915611666 @default.
• W4205741365 cites W2946558957 @default.
• W4205741365 cites W2952676090 @default.
• W4205741365 cites W2969608196 @default.
• W4205741365 cites W2970987540 @default.
• W4205741365 cites W2975417827 @default.
• W4205741365 cites W2976156847 @default.
• W4205741365 cites W2981892037 @default.
• W4205741365 cites W3037391733 @default.
• W4205741365 cites W3110407364 @default.
• W4205741365 cites W3124955349 @default.
• W4205741365 doi "https://doi.org/10.3892/etm.2022.11132" @default.
• W4205741365 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35126712" @default.
• W4205741365 hasPublicationYear "2022" @default.
• W4205741365 type Work @default.
• W4205741365 citedByCount "4" @default.
• W4205741365 countsByYear W42057413652022 @default.
• W4205741365 countsByYear W42057413652023 @default.
• W4205741365 crossrefType "journal-article" @default.
• W4205741365 hasAuthorship W4205741365A5023541354 @default.
• W4205741365 hasAuthorship W4205741365A5027312456 @default.
• W4205741365 hasAuthorship W4205741365A5031337173 @default.
• W4205741365 hasAuthorship W4205741365A5036476484 @default.
• W4205741365 hasAuthorship W4205741365A5038839605 @default.
• W4205741365 hasAuthorship W4205741365A5047835985 @default.
• W4205741365 hasAuthorship W4205741365A5068252474 @default.
• W4205741365 hasAuthorship W4205741365A5089119541 @default.
• W4205741365 hasBestOaLocation W42057413651 @default.
• W4205741365 hasConcept C121608353 @default.
• W4205741365 hasConcept C190283241 @default.
• W4205741365 hasConcept C2776231280 @default.
• W4205741365 hasConcept C2776248978 @default.
• W4205741365 hasConcept C2778019345 @default.
• W4205741365 hasConcept C2781450507 @default.
• W4205741365 hasConcept C502942594 @default.
• W4205741365 hasConcept C526805850 @default.
• W4205741365 hasConcept C54355233 @default.
• W4205741365 hasConcept C55493867 @default.
• W4205741365 hasConcept C62112901 @default.
• W4205741365 hasConcept C75217442 @default.
• W4205741365 hasConcept C86554907 @default.
• W4205741365 hasConcept C86803240 @default.
• W4205741365 hasConcept C96232424 @default.
• W4205741365 hasConcept C98274493 @default.
• W4205741365 hasConceptScore W4205741365C121608353 @default.
• W4205741365 hasConceptScore W4205741365C190283241 @default.
• W4205741365 hasConceptScore W4205741365C2776231280 @default.
• W4205741365 hasConceptScore W4205741365C2776248978 @default.
• W4205741365 hasConceptScore W4205741365C2778019345 @default.
• W4205741365 hasConceptScore W4205741365C2781450507 @default.
• W4205741365 hasConceptScore W4205741365C502942594 @default.
• W4205741365 hasConceptScore W4205741365C526805850 @default.
• W4205741365 hasConceptScore W4205741365C54355233 @default.
• W4205741365 hasConceptScore W4205741365C55493867 @default.
• W4205741365 hasConceptScore W4205741365C62112901 @default.
• W4205741365 hasConceptScore W4205741365C75217442 @default.
• W4205741365 hasConceptScore W4205741365C86554907 @default.
• W4205741365 hasConceptScore W4205741365C86803240 @default.
• W4205741365 hasConceptScore W4205741365C96232424 @default.
• W4205741365 hasConceptScore W4205741365C98274493 @default.
• W4205741365 hasIssue "3" @default.

• next